300
Participants
Start Date
Not specified
Study Completion Date
February 28, 2002
Indinavir sulfate
Lamivudine/Zidovudine
Ritonavir
Amprenavir
Efavirenz
Saquinavir
Lamivudine
Stavudine
Zidovudine
Didanosine
Beth Israel Med Ctr, New York
Bellevue Hosp / New York Univ Med Ctr, New York
Chelsea Ctr, New York
Cornell Univ Med Ctr, New York
Mount Sinai Med Ctr, New York
SUNY / Erie County Med Ctr at Buffalo, Buffalo
Univ of Rochester Medical Center, Rochester
Univ of Pennsylvania at Philadelphia, Philadelphia
Howard Univ, Washington D.C.
Duke Univ Med Ctr, Durham
Julio Arroyo, West Columbia
Emory Univ, Atlanta
Univ of Alabama at Birmingham, Birmingham
Case Western Reserve Univ, Cleveland
Division of Inf Diseases/ Indiana Univ Hosp, Indianapolis
Methodist Hosp of Indiana / Life Care Clinic, Indianapolis
Northwestern Univ Med School, Chicago
Cook County Hosp, Chicago
Rush Presbyterian - Saint Luke's Med Ctr, Chicago
St Louis Regional Hosp / St Louis Regional Med Ctr, St Louis
Univ of Colorado Health Sciences Ctr, Denver
UCLA CARE Ctr, Los Angeles
Willow Clinic, Menlo Park
Marin County Specialty Clinic, San Rafael
Univ of Washington, Seattle
Univ of North Carolina, Chapel Hill
Univ of Miami School of Medicine, Miami
Ohio State Univ Hosp Clinic, Columbus
Univ of Cincinnati, Cincinnati
Indiana Univ Hosp, Indianapolis
Univ of Southern California / LA County USC Med Ctr, Los Angeles
San Francisco AIDS Clinic / San Francisco Gen Hosp, San Francisco
San Francisco Gen Hosp, San Francisco
San Mateo AIDS Program / Stanford Univ, Stanford
Stanford Univ Med Ctr, Stanford
Santa Clara Valley Med Ctr / AIDS Community Rsch Consortium, San Jose
Harvard (Massachusetts Gen Hosp), Boston
Beth Israel Deaconess - West Campus, Boston
Univ of Puerto Rico, San Juan
National Institute of Allergy and Infectious Diseases (NIAID)
NIH